Association study of sporadic Parkinson's disease genetic risk factors in patients from Russia by APEX technology

Neuroscience Letters

Volumn 405, Issue 3, 2006, Pages 212-216

  Shadrina, Maria ^a   Nikopensius, Tiit ^b   Slominsky, Petr ^a   Illarioshkin, Sergei ^c   Bagyeva, Gulbahar ^c   Markova, Elene ^c   Ivanova Smolenskaia, Irina ^c   Kurg, Ants ^b   Limborska, Svetlana ^a   Metspalu, Andres ^b  

^a INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^b UNIVERSITY OF TARTU   (Estonia)

^c RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

Author keywords

APEX technology; Parkinson disease; Single nucleotide polymorphisms

Indexed keywords

CHOLECYSTOKININ; DOPAMINE; NEUROTRANSMITTER; OPIATE; PROOPIOMELANOCORTIN; SEROTONIN; SEROTONIN 2A RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; RUSSIAN FEDERATION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; WOLFRAM SYNDROME;

AGED; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRO-OPIOMELANOCORTIN; RECEPTOR, SEROTONIN, 5-HT2A; RISK FACTORS; RUSSIA;

EID: 33746870393     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.06.066     Document Type: Article

References (22)

1. D'Amato R.J., Zweig R.M., Whitehouse P.J., Wenk G.L., Singer H.S., Mayeux R., Price D.L., and Snyder S.H. Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann. Neurol. 22 (1987) 229-236
2. Dawson E., Abecasis G.R., Bumpstead S., Chen Y., Hunt S., Beare D.M., Pabial J., Dibling T., Tinsley E., Kirby S., Carter D., Papaspyridonos M., Livingstone S., Ganske R., Lohmussaar E., Zernant J., Tonisson N., Remm M., Magi R., Puurand T., Vilo J., Kurg A., Rice K., Deloukas P., Mott R., Metspalu A., Bentley D.R., Cardon L.R., and Dunham I. A first-generation linkage disequilibrium map of human chromosome 22. Nature 418 (2002) 544-548
3. Dolotov O.V., Seredenina T.S., Levitskaya N.G., Kamensky A.A., Andreeva L.A., Alfeeva L.Y., Nagaev I.Y., Zolotarev Y.A., Grivennikov I.A., Engele Y., and Myasoedov N.F. The heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain in vivo. Dokl. Biol. Sci. 391 (2003) 292-295
4. Galloway M.P., Suchowski C.S., Keegan M.J., and Hjorth S. Local infusion of the selective 5HT-1b agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse 15 (1993) 90-92
5. Huang Y., Cheung L., Rowe D., and Halliday G. Genetic contributions to Parkinson's disease. Brain Res. Rev. 46 (2004) 44-70
6. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracay of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55 (1992) 181-184
7. Illarioshkin S.N., Periquet M., Rawal N., Lucking C.B., Zagorovskaya T.B., Slominsky P.A., Miloserdova O.V., Markova E.D., Limborska S.A., Ivanova-Smolenskaya I.A., and Brice A. Mutation analysis of the parkin gene in Russian families with autosomal recessive juvenile parkinsonism. Mov. Disord. 18 (2003) 914-919
8. Jaakson K., Zernant J., Kulm M., Hutchinson A., Tonisson N., Glavac D., Ravnik-Glavac M., Hawlina M., Meltzer M.R., Caruso R.S., Testa F., Maugeri A., Hoyng C.B., Gouras P., Simonelli F., Lewis R.A., Lupski J.R., Cremers F.P., and Allikmets R. Genotyping microarray (gene chip) for the ABCR (ABCA4) gene. Hum. Mutat. 22 (2003) 395-403
9. Khanim F., Kirk J., Latif F., and Barrett T.G. WFS1/wolframin mutations, Wolfram syndrome, and associated diseases. Hum. Mutat. 17 (2001) 357-367
10. Kurg A., Tonisson N., Georgiou I., Shumaker J., Tollett J., and Metspalu A. Arrayed primer extension: solid-phase four-color DNA resequencing and mutation detection technology. Genet. Test 4 (2000) 1-7
11. Lalouel J.M., and Rohrwasser A. Power and replication in case-control studies. Am. J. Hypertens. 15 (2002) 201-205
12. Maron E., Nikopensius T., Koks S., Altmae S., Heinaste E., Vabrit K., Tammekivi V., Hallast P., Koido K., Kurg A., Metspalu A., Vasar E., Vasar V., and Shlik J. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr. Genet. 15 (2005) 17-24
13. McCann S.J., McManus M.E., Johnson A.G., Mellick G.D., Le Couteur D.G., and Pond S.M. The serotonin transporter gene and Parkinson's disease. Eur. Neurol. 44 (2000) 108-111
14. Messina D., Annesi G., and Serra P. Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson's disease. Neurology 58 (2002) 828-829
15. Miller S.A., Dykes D.D., and Polesky H.F. A sample salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 16 (1988) 1215
16. Ng N.K., Lee H.S., and Wong P.T. Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors. J. Neurosci. Res. 55 (1999) 600-607
17. Nussbaum R.L., and Polymeropoulos M.H. Genetics of Parkinson's disease. Hum. Mol. Genet. 6 (1997) 1687-1691
18. Pankratz N., Nichols W.C., Uniacke S.K., Halter C., Rudolph A., Shults C., Conneally P.M., Foroud T., and Parkinson Study Group. Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am. J. Hum. Genet. 71 (2002) 124-135
19. Polymeropoulos M.H., Higgins J.J., Golbe L.I., Johnson W.G., Ide S.E., Di Iorio G., Sanges G., Stenroos E.S., Pho L.T., Schaffer A.A., Lazzarini A.M., Nussbaum R.L., and Duvoisin R.S. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274 (1996) 1197-1199
20. Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A., Hiner B.C., Jankovic J., Ondo W.G., Allen F.H., Goetz C.G., Small G.W., Masterman D., Mastaglia F., Laing N.G., Stajich J.M., Slotterbeck B., Booze M.W., Ribble R.C., Rampersaud E., West S.G., Gibson R.A., Middleton L.T., Roses A.D., Haines J.L., Scott B.L., Vance J.M., and Pericak-Vance M.A. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA 286 (2001) 2239-2244
21. Shadrina M.I., Dolotov O.V., Grivennikov I.A., Slominsky P.A., Andreeva L.A., Inozemtseva L.S., Limborska S.A., and Myasoedov N.F. Rapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an adrenocorticotropic hormone analog. Neurosci. Lett. 308 (2001) 115-118
22. Wood N.W. Genetic risk factors in Parkinson's disease. Ann. Neurol. 44 (1998) 58-62